Hypnosis Vs. Anti-depressants For Treating Depression
Which face are you wearing today?
Treating depression with anti-depressants is, in my opinion, treating the person from the outside in. It’s like blindfolding someone and hoping they can find their way in the dark… sometimes they can find their way – with bumps and bruises (side effects); and sometimes they can’t (often resulting in more medication, change of medication – in the hope that something works; or upset, frustrated people).
Taking anti-depressants is ‘moving away’ from depression. In life, if we ‘move away’ from something we will see-saw back and forth between being ok and not being ok. The problem never really gets solved, just masked – and it comes and goes.
If we want to live a life full of happiness we need to be ‘moving towards’ something (ie. Happiness). Hypnosis and NLP can help you do that. People who ‘move towards’ happiness will find that they have positive, consistent results and they leave the past behind them.
Every person is an individual and should be treated as such. I believe that this can more effectively be done by treating the person from the inside, helping them to remove that blindfold and showing them the light switch.
The old saying: “give a man a fish and feed him for a day, teach a man to fish and you feed him for life” comes to mind. I teach all of my clients self-hypnosis and strategies to move towards whatever it is that they want to move towards.
Hypnosis can help you, as it has countless others, feel the way you really want to feel. I have helped many people come off anti-depressants (under the supervision of their doctors) and begin leading the lives they’ve always wanted. Are you moving towards or away from?
Below: more evidence that anti-depressants aren’t all they’re professed to be:
Increasingly over the last few years, the relationship between pharmaceutical companies and doctors and pharmacists has come under scrutiny. (This is highlighted in the articles below).
“Antidepressant reboxetine no better than a placebo, study finds Scientists accuse Pfizer of holding back studies which reveal drug sold as Edronax to be ineffective and potentially harmful.”
To read the full article visit www.guardian.co.uk/reboxetine-pfizer-antidepressant-placebo
“European pharmaceutical companies accused of unfair marketing. Major European pharmaceutical companies have been accused of using unscrupulous marketing practices to try to get doctors to prescribe their products, and persuade consumers that they need them. Drugs companies spend twice as much money on marketing as they do on research, Consumers International says. Last year that amounted to $60 billion being lavished on sales promotion in Europe.”
To read the full article visit www.abc.net.au/news/stories/2006/06/26/1672315.htm
